Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02993991
Title Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity
Acronym PRIMED-001
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.